Rchr
J-GLOBAL ID：200901082912583460   Update date: Aug. 29, 2023

Shimasaki Takeo

シマサキ タケオ | Shimasaki Takeo
Affiliation and department：
Kanazawa Medical University School of Medicine, Department of Medical Oncology

About Kanazawa Medical University School of Medicine, Department of Medical Oncology


Job title： Assistant Professor
Research theme for competitive and other funds  (9)：
  • 2018 - 2020 膵がん細胞のexosomeを介した浸潤性伝播の解明とその抑制剤の開発
  • 2015 - 2017 抗がん剤による膵がん細胞の浸潤形質獲得の分子機構の解明とがん治療への応用
  • 2015 - 2015 進行膵癌とそのエキソソームをダブルターゲットとした治療薬の開発
  • 2013 - 2013 GSK3βを標的治療とした既存医薬品による膵がんの新規治療
  • 2011 - 2013 化学療法により誘発されるEMT誘導因子の同定とその制御による膵がん治療法の開発
Show all
Papers (53)：
ｍore...
Books (4)：
  • Distinct pathologic role for glycogen synthase kinase 3β in colorectal cancer progression
    InTech 2012 ISBN:9789535100621
  • Stress responses of pancreatic cancer cells and their significance in invasion and metastasis
    Springer 2012
  • コラム4: ステージ分類とは?,第7章がんについてよくある質問: がん登録とは?
    2010
  • Gemcitabine changes the gene expression in human pancreatic cancer cells :search for new therapeutic molecular targets
    Springer 2009
Lectures and oral presentations  (101)：
  • Inhibitor of GSK3β may impedes the Development of Reflux-Induced Esophageal
    (The 33rd Annual Meeting of the Japanese Society for Gastroenterological Carcinogenesis 2022)
  • THE PRE-MICRORNA938,TARGETING 1L-17L 3'-UTR,GENE POLYMORPHISMS IS ASSOCIATED WITH THE RISK FOR DAP-KINASE HYPERMETHYLATION IN HP INFECTED JAPANESE SUBJECTS
    (DDW2017 2017)
  • Observation of extracellular vesicles under scanning electron microscope
    (2015)
  • ヒト由来細胞外小胞の解析
    (2015)
  • Identification of the GSK3 beta-mediated secretory protein responsible for GEM-induced EMT in pancreatic cancer cells.
    (2014)
ｍore...
Education (2)：
  • 1997 - 2002 Kanazawa University Graduate School
  • 1987 - 1993 Hamamatsu University School of Medicine Faculty of Medicine
Professional career (1)：
  • Ph.D in Medicine
Awards (6)：
  • 2013/03 - Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
  • 2013/03 - 日本消化器病学会 日本消化器病学会奨励賞 Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
  • 2013 - Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. J Gastroenterol, 47(3):321-33, 2012.
  • 2013 - 金沢医科大学医学会 金沢医科大学医学会「論文表彰」 Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. J Gastroenterol, 47(3):321-33, 2012.
  • 2012/11 - GSK3B異常活性による膵がんの浸潤と治療抵抗性
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM